# Effects of Silybin in Hypertensive Patients

> **NCT03538327** · PHASE4 · COMPLETED · sponsor: **University Magna Graecia** · enrollment: 50 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Silybin

## Key facts

- **NCT ID:** NCT03538327
- **Lead sponsor:** University Magna Graecia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-04
- **Final completion:** 2014-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03538327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03538327, "Effects of Silybin in Hypertensive Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03538327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*